Variant report
Variant | nsv528090 |
---|---|
Chromosome Location | chr13:62175238-62190998 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17060094 | chr13:62175238-62175239 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs563442396 | chr13:62175266-62175267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533675206 | chr13:62175320-62175321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547168937 | chr13:62175339-62175340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149335443 | chr13:62175366-62175367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376709175 | chr13:62175381-62175382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112699175 | chr13:62175388-62175389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371865995 | chr13:62175400-62175401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183245967 | chr13:62175437-62175438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540345260 | chr13:62175441-62175442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535906545 | chr13:62175493-62175494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534966515 | chr13:62175524-62175525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547467942 | chr13:62175531-62175532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566076490 | chr13:62175532-62175533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549190215 | chr13:62175537-62175538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370075847 | chr13:62175545-62175546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148035354 | chr13:62175554-62175555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187015475 | chr13:62175568-62175569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191941025 | chr13:62175605-62175606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141668044 | chr13:62175612-62175613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555586430 | chr13:62175614-62175615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368475702 | chr13:62175661-62175662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10681850 | chr13:62175679-62175680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2876806 | chr13:62175686-62175687 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs73214016 | chr13:62175709-62175710 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs534281314 | chr13:62175721-62175722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73214017 | chr13:62175752-62175753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577586326 | chr13:62175754-62175755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9570602 | chr13:62175769-62175770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183567484 | chr13:62175963-62175964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530653644 | chr13:62175975-62175976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186707694 | chr13:62176027-62176028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189986260 | chr13:62176047-62176048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528336172 | chr13:62176056-62176057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182348084 | chr13:62176065-62176066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577470029 | chr13:62176096-62176097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9598324 | chr13:62176109-62176110 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs79900313 | chr13:62176110-62176111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551395663 | chr13:62176244-62176245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192917854 | chr13:62176251-62176252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569811877 | chr13:62176265-62176266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139880525 | chr13:62176275-62176276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555639794 | chr13:62176295-62176296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9598325 | chr13:62176296-62176297 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs534977599 | chr13:62176343-62176344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185006638 | chr13:62176386-62176387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs578210886 | chr13:62176402-62176403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369314708 | chr13:62176408-62176409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143161101 | chr13:62176423-62176424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557044830 | chr13:62176424-62176425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Esophageal squamous carcinoma | 20200074 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Bipolar disorder | 19214233 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:62174400-62175800 | Enhancers | Liver | Liver |
2 | chr13:62174600-62175400 | Enhancers | Brain Cingulate Gyrus | brain |
3 | chr13:62174800-62175400 | Enhancers | Brain Angular Gyrus | brain |
4 | chr13:62174800-62175800 | Enhancers | Brain Inferior Temporal Lobe | brain |
5 | chr13:62175000-62175800 | Enhancers | Brain Substantia Nigra | brain |
6 | chr13:62175200-62177000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr13:62175200-62177800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr13:62177000-62178800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr13:62177800-62179000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr13:62179000-62182400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr13:62182000-62182200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr13:62182000-62183000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr13:62182000-62183000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr13:62182200-62182400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr13:62182200-62182400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr13:62182200-62182800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr13:62182200-62183000 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr13:62182200-62183000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr13:62182400-62183000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr13:62182600-62183000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr13:62182800-62183000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
22 | chr13:62183200-62183400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |